These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30363900)

  • 21. [The clinical value of SUDOSCAN in diagnosis of diabetic distal symmetrical peripheral neuropathy].
    Ma JJ; Hao SL; Cheng XT; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(15):1170-1174. PubMed ID: 28427125
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and tolerability of controlled-release oxycodone for oxaliplatin-induced peripheral neuropathy and the extension of FOLFOX therapy in advanced colorectal cancer patients.
    Nagashima M; Ooshiro M; Moriyama A; Sugishita Y; Kadoya K; Sato A; Kitahara T; Takagi R; Urita T; Yoshida Y; Tanaka H; Oshiro T; Okazumi S; Katoh R
    Support Care Cancer; 2014 Jun; 22(6):1579-84. PubMed ID: 24452412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Accuracy of Electrochemical Skin Conductance in the Detection of Sudomotor Fiber Loss.
    Porubcin MG; Novak P
    Front Neurol; 2020; 11():273. PubMed ID: 32425871
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy.
    Goel A; Shivaprasad C; Kolly A; Sarathi H A V; Atluri S
    PLoS One; 2017; 12(9):e0183973. PubMed ID: 28880907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study.
    Velasco R; Navarro X; Gil-Gil M; Herrando-Grabulosa M; Calls A; Bruna J
    J Pain Symptom Manage; 2017 Dec; 54(6):815-825. PubMed ID: 28797868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
    Smith EM; Pang H; Ye C; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Le-Lindqwister N; Fadul CE; Loprinzi C; Shapiro CL;
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26603828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrochemical Skin Conductance and Quantitative Sensory Testing on Fibromyalgia.
    Pickering G; Achard A; Corriger A; Sickout-Arondo S; Macian N; Leray V; Lucchini C; Cardot JM; Pereira B
    Pain Pract; 2020 Apr; 20(4):348-356. PubMed ID: 31705738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development.
    Yang Y; Zhao B; Gao X; Sun J; Ye J; Li J; Cao P
    J Exp Clin Cancer Res; 2021 Oct; 40(1):331. PubMed ID: 34686205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electronic von Frey as an objective assessment tool for oxaliplatin-induced peripheral neuropathy: A prospective longitudinal study.
    Godinho PAR; Silva PGB; Lisboa MRP; Costa BA; Gifoni MAC; Rocha Filho DR; Lima-Júnior RCP; Vale ML
    Eur J Cancer Care (Engl); 2021 Jan; 30(1):e13360. PubMed ID: 33219575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive clinical factors of chronic peripheral neuropathy induced by oxaliplatin.
    Yildirim N; Cengiz M
    Support Care Cancer; 2020 Oct; 28(10):4781-4788. PubMed ID: 31974772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sudomotor Testing of Diabetes Polyneuropathy.
    Krieger SM; Reimann M; Haase R; Henkel E; Hanefeld M; Ziemssen T
    Front Neurol; 2018; 9():803. PubMed ID: 30319533
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantification of Chronic Oxaliplatin-Induced Hypesthesia in Two Areas of the Hand.
    Andriamamonjy M; Delmotte JB; Savinelli F; Beaussier H; Coudoré F
    J Clin Neurophysiol; 2017 Mar; 34(2):126-131. PubMed ID: 27749615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice.
    Lamoine S; Cumenal M; Barriere DA; Pereira V; Fereyrolles M; Prival L; Barbier J; Boudieu L; Brasset E; Bertin B; Renaud Y; Miot-Noirault E; Civiale MA; Balayssac D; Aissouni Y; Eschalier A; Busserolles J
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic usefulness of the combined COMPASS 31 questionnaire and electrochemical skin conductance for diabetic cardiovascular autonomic neuropathy and diabetic polyneuropathy.
    D'Amato C; Greco C; Lombardo G; Frattina V; Campo M; Cefalo CMA; Izzo V; Lauro D; Spallone V
    J Peripher Nerv Syst; 2020 Mar; 25(1):44-53. PubMed ID: 31985124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.
    Xiao WH; Zheng H; Bennett GJ
    Neuroscience; 2012 Feb; 203():194-206. PubMed ID: 22200546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy.
    Cao Y; Chang Q; Zhang W; Ornatsky O; Hedley D; Chen EX
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1195-1200. PubMed ID: 31520102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new monitoring tool CLIP test for progression of oxaliplatin-induced peripheral neuropathy: A multicenter prospective study.
    Kamei K; Ohnishi T; Nakata K; Danno K; Ohkawa A; Miyake Y; Okazaki S; Fukunaga M; Toyokawa A; Hamada T; Shindoh J; Kanazawa A
    Asia Pac J Clin Oncol; 2020 Oct; 16(5):e257-e262. PubMed ID: 32893979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction.
    Casellini CM; Parson HK; Richardson MS; Nevoret ML; Vinik AI
    Diabetes Technol Ther; 2013 Nov; 15(11):948-53. PubMed ID: 23889506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel.
    Ventzel L; Jensen AB; Jensen AR; Jensen TS; Finnerup NB
    Pain; 2016 Mar; 157(3):560-568. PubMed ID: 26529271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors for development of oxaliplatin-induced peripheral neuropathy in cancer patients as determined by ordered logistic regression analysis.
    Kanbayashi Y; Ishikawa T; Kuriu Y; Otsuji E; Takayama K
    PLoS One; 2022; 17(9):e0275481. PubMed ID: 36174022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.